Bio-Techne Corp (TECH) - Total Liabilities
Based on the latest financial reports, Bio-Techne Corp (TECH) has total liabilities worth $465.30 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Bio-Techne Corp equity growth rate to track the company's year-over-year net asset growth rate.
Bio-Techne Corp - Total Liabilities Trend (1989–2025)
This chart illustrates how Bio-Techne Corp's total liabilities have evolved over time, based on quarterly financial data. See TECH cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Bio-Techne Corp Competitors by Total Liabilities
The table below lists competitors of Bio-Techne Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LG Corp
KO:003550
|
Korea | ₩3.65 Trillion |
|
Mowi ASA
OL:MOWI
|
Norway | Nkr5.86 Billion |
|
Leonardo DRS, Inc. Common Stock
NASDAQ:DRS
|
USA | $1.44 Billion |
|
Webster Financial Corporation
NYSE:WBS
|
USA | $74.58 Billion |
|
WOORI FIN. GRP SP.ADR/3
F:2WGA
|
Germany | €563.60 Trillion |
|
ALTEOGEN Inc
KQ:196170
|
Korea | ₩216.61 Billion |
|
Guangdong Haid Group Co Ltd
SHE:002311
|
China | CN¥25.73 Billion |
|
HudBay Minerals Inc
TO:HBM
|
Canada | CA$2.90 Billion |
Liability Composition Analysis (1989–2025)
This chart breaks down Bio-Techne Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TECH company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bio-Techne Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bio-Techne Corp (1989–2025)
The table below shows the annual total liabilities of Bio-Techne Corp from 1989 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $639.06 Million | +0.64% |
| 2024-06-30 | $635.02 Million | -5.53% |
| 2023-06-30 | $672.18 Million | +13.20% |
| 2022-06-30 | $593.79 Million | -14.16% |
| 2021-06-30 | $691.72 Million | +7.01% |
| 2020-06-30 | $646.40 Million | -10.08% |
| 2019-06-30 | $718.82 Million | +39.83% |
| 2018-06-30 | $514.06 Million | -15.15% |
| 2017-06-30 | $605.83 Million | +142.11% |
| 2016-06-30 | $250.23 Million | +15.62% |
| 2015-06-30 | $216.43 Million | +221.94% |
| 2014-06-30 | $67.23 Million | +65.76% |
| 2013-06-30 | $40.56 Million | -9.64% |
| 2012-06-30 | $44.88 Million | +42.27% |
| 2011-06-30 | $31.55 Million | +85.31% |
| 2010-06-30 | $17.02 Million | +9.67% |
| 2009-06-30 | $15.52 Million | -23.30% |
| 2008-06-30 | $20.24 Million | +17.72% |
| 2007-06-30 | $17.19 Million | -43.00% |
| 2006-06-30 | $30.16 Million | +10.11% |
| 2005-06-30 | $27.39 Million | -2.29% |
| 2004-06-30 | $28.04 Million | +5.16% |
| 2003-06-30 | $26.66 Million | -15.98% |
| 2002-06-30 | $31.73 Million | -16.20% |
| 2001-06-30 | $37.86 Million | -3.56% |
| 2000-06-30 | $39.26 Million | +45.42% |
| 1999-06-30 | $27.00 Million | +196.70% |
| 1998-06-30 | $9.10 Million | +56.90% |
| 1997-06-30 | $5.80 Million | +5.45% |
| 1996-06-30 | $5.50 Million | +19.57% |
| 1995-06-30 | $4.60 Million | +21.05% |
| 1994-06-30 | $3.80 Million | +46.15% |
| 1993-06-30 | $2.60 Million | -42.22% |
| 1992-06-30 | $4.50 Million | +36.36% |
| 1991-06-30 | $3.30 Million | -2.94% |
| 1990-06-30 | $3.40 Million | +13.33% |
| 1989-06-30 | $3.00 Million | -- |
About Bio-Techne Corp
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various asp… Read more